指南与共识重症综合管理与镇静镇痛

印度重症医学会重症监护病房静脉血栓栓塞预防共识声明

Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit.
指南 / 共识 · Indian J Crit Care Med · 2022-01-01
一句话结论印度重症医学会发布共识,强调以临床终点大型RCT为依据、在证据不确切时明确承认不确定性,避免教条式推荐。

该共识由印度重症医学会制定,针对重症监护病房静脉血栓栓塞预防,旨在提供务实方法。声明指出既往指南繁多且常被误读,读者常混淆推荐等级与证据水平、忽略「建议」与「推荐」的差异。声明优先采纳以临床终点的 大型随机对照试验,弱化替代终点RCT及假设生成性研究(观察性研究、小型RCT及其荟萃分析),并弱化非ICU人群(术后、肿瘤、卒中)的RCT。同时考虑资源有限环境,避免推荐昂贵且证据不足的治疗选项;作者认为真正的模糊优于不准确的确定性。

要点

  • 声明优先采纳以临床终点的大型随机对照试验,弱化替代终点RCT及观察性研究、小型RCT及其荟萃分析等假设生成性研究。
  • 声明弱化非ICU人群(如术后患者、肿瘤或卒中患者)的RCT证据,并考虑资源有限环境,避免推荐昂贵且证据不足的治疗选项。
  • 声明强调需区分推荐等级与证据水平,以及「我们建议」与「我们推荐」的差异,在证据不确切时明确说明模糊性。
  • 作者认为真正的模糊优于不准确的确定性,读者可能对缺乏具体推荐感到不满。

适用人群与场景

  • 重症监护病房患者,用于静脉血栓栓塞预防。

研究设计与关键结果

  • 制定机构为印度重症医学会,制定方法为共识声明,声明试图遵循关于如何制定指南的指南并克服对这些指南依从性差的问题。
  • 声明优先采纳以临床终点的大型随机对照试验,弱化替代终点RCT及假设生成性研究(观察性研究、小型RCT及这些研究的荟萃分析)。
  • 声明弱化非ICU人群(如术后患者、肿瘤或卒中患者)的RCT,并考虑资源有限环境,避免推荐昂贵且证据不足的治疗选项。
  • 声明强调需区分推荐等级与证据水平以及「我们建议」与「我们推荐」的差异,并在证据不确切时明确说明模糊性。

证据类型、等级与局限

  • 证据类型:共识声明。
  • 声明优先采纳以临床终点的大型随机对照试验,弱化替代终点RCT及假设生成性研究。
  • 声明弱化非ICU人群(如术后患者、肿瘤或卒中患者)的RCT。

对床旁实践的改变

  • 作者认为真正的模糊优于不准确的确定性,在证据不确切时明确说明模糊性,避免教条式推荐。
  • 作者认为读者和执业者可能对缺乏具体推荐感到不满,但声明仍坚持此立场。

指南或共识出处

  • 印度重症医学会重症监护病房静脉血栓栓塞预防共识声明(Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit),印度重症医学会,2022年,Indian J Crit Care Med 2022;26(S2):S51-S65。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Deep vein thrombosis (DVT) is a preventable complication of critical illness, and this guideline aims to convey a pragmatic approach to the problem. Guidelines have multiplied over the last decade, and their utility has become increasingly conflicted as the reader interprets all suggestions or recommendations as something that must be followed. The nuances of grade of recommendation vs level of evidence are often ignored, and the difference between a "we suggest" vs a "we recommend" is overlooked. There is a general unease among clinicians that failure to follow the guidelines translates to poor medical practice and legal culpability. We attempt to overcome these limitations by highlighting ambiguity when it occurs and refraining from dogmatic recommendations in the absence of robust evidence. Readers and practitioners may find the lack of specific recommendations unsatisfactory, but we believe that true ambiguity is better than inaccurate certainty. We have attempted to comply with the guidelines on how to create guidelines.1 And to overcome the poor compliance with these guidelines.2 Some observers have expressed concern that DVT prophylaxis guidelines may cause more harm than good.3 We have placed greater emphasis on large randomized controlled trials (RCTs) with clinical end point and de-emphasized RCTs with surrogate end points and also de-emphasized hypothesis generating studies (observational studies, small RCTs, and meta-analysis of these studies). We have de-emphasized RCTs in non-intensive care unit populations like postoperative patients or those with cancer and stroke. We have also considered resource limitation settings and have avoided recommending costly and poorly proven therapeutic options.

HOW TO CITE THIS ARTICLE: Jagiasi BG, Chhallani AA, Dixit SB, Kumar R, Pandit RA, Govil D, et al. Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit. Indian J Crit Care Med 2022;26(S2):S51-S65.

来源:Indian J Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Jagiasi BG, Chhallani AA, Dixit SB, et al. Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit. Indian J Crit Care Med. 2022. PMID: 36896363. doi:10.5005/jp-journals-10071-24195

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。